Business
PCA Dealing
Tristel plc announced that Glenn Stephens, acting as a person closely associated with Non-Executive Director Caroline Stephens, purchased 2,310 ordinary shares at 389 pence per share on March 3, 2026. This transaction brings Caroline Stephens' total beneficial interest, including those held by her PCA, to 4,281 ordinary shares, representing approximately 0.01% of the company's issued share capital. Disclaimer*
About this update from Tristel Plc
Tristel plc ("Tristel" or the "Company") PCA Dealing Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that it was notified on 3 March 2026 that Glenn Stephens, a PCA of Caroline Stephens, Non-Executive Director of the Company, purchased 2,310 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 389 pence per Ordinary Share. Following the purchase, Caroline Stephens' beneficial interest in the Company, including those held by her PCA, is 4,281 Ordinary Shares, representing approximately 0.01 per cent. of the Company's issued share capital. For further information please contact: Tristel plc Via Walbrook PR Matt Sassone, Chief Executive Officer www.investors.tristel.com Anna Wasyl, Chief Financial Officer Walbrook PR Ltd Tel: 020 7933 8780 or [email protected] Paul McManus / Lianne Applegarth / Anna Dunphy Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 Cavendish Capital Markets Ltd Tel: 020 7220 0500 Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance) Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) About Tristel plc Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals with products under the Tristel brand, which also encompasses its sporicidal surface disinfection range offered as a sustainable alternative to commonly used pre‑wetted plastic wipe. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets delivering double-digit revenue growth annually, an adjusted EBITDA margin of at least 25% and a continuing progressive year-on-year growth in dividends, underpinned by robust cash generation. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com 1 Details of the person discharging managerial responsibilities / person closely a...